ACE2 is a crucial component in the regulation of the cardiovascular system, and its interaction with the virus may lead to direct myocardial injury, contributing to adverse outcomes in COVID-19 patients with pre-existing heart conditions. This evidence concerns the gene ACE2 and COVID-19.